CLINICAL_TRIALS
trial_result
· 2017-05-16
Clinical Trial Update: Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole [Phase 4]
Summary
A Phase 4 trial investigating pramipexole for major depressive disorder focused on nucleus accumbens imaging and was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Depression | Phase 4 | Status: TERMINATED | Results posted: 2017-05-16